Parallel Advisors’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
Parallel Advisors's ATEX Position: Q1 2026 in Review
Parallel Advisors increased its Anterix (ATEX) stake by 64% in Q1 2026, buying an estimated $11.5K and bringing the position to 933 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.
Parallel Advisors first reported a position in ATEX in Q2 2020 and has held it in 24 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- Parallel Advisors held 933 shares of Anterix worth $35.6K as of Q1 2026.
- Parallel Advisors bought 363 Anterix shares in Q1 2026, an estimated $11.5K.
- Anterix made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2193 holding.
- Parallel Advisors first reported a position in Anterix in Q2 2020 and has held it in 24 quarters since.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.